Categories: Research

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Table of contents


Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support

Logic gates allow bacteria to work like computers

Logic gates, similar to those that form the basis of silicon computing, can now be inserted into bacteria via genetic engineering, making it possible to manipulate bacteria to perform complicated tasks. This finding will ultimately enable cells to be programmed with more intricate functions,...

SmartPlanet video features The Kidney Project

The implantable bioartificial kidney is explained in this December 6, 2010, SmartPlanet video featuring Shuvo Roy, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine.

Roy shares promise of bioartificial kidney

Shuvo Roy, PhD, an engineer and research scientist, is leading a U.S. project to build the world’s first bioartificial kidney to treat end stage renal disease. The goal is to surgically implant this coffee-cup-sized device in a human patient within 5 to 7 years.

Ortiz de Montellano named associate dean

Paul Ortiz de Montellano, PhD, is the newly appointed associate dean of research in the UCSF School of Pharmacy.

Huang receives Packard Fellowship

Bo Huang, PhD, a faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, has received one of 17 prestigious 2010 Packard Fellowships in Science and Engineering, which supports "unusually creative professors" early in their careers.

Giacomini to receive Therapeutic Frontiers Lecture Award

Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, will receive the 2010 Therapeutic Frontiers Lecture Award from the American College of Clinical Pharmacy on October 17, 2010, in Austin, Texas at

Animation shows bioartificial kidney in action

A national research project is under way to develop an surgically implantable bioartificial kidney using the latest advances in science and technology with the goal of both improving the health and lives of patients with end stage renal disease and saving health care dollars.

Fischbach receives New Innovator Award

Michael Fischbach, PhD, is the recipient of a 2010 NIH Director’s New Innovator Award from the National Institutes of Health.

Giacomini to lead $15.1 million in research funding to improve the use of drugs in individuals

Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences and an expert in the field of pharmacogenomics, is leading two research projects funded by two grants totaling $15.1 million over the next five years to expand research into how ge

Pages